ChordNews
← All news

Iradimed expects Q4 revenue of $25M-$26.5M and targets 50%+ sequential growth in 3870 pump output

By ChordNews · First written

Comments 0

Summary

A Seeking Alpha headline reports that Iradimed anticipates fourth-quarter revenue of $25 million to $26.5 million, and that output of its 3870 pump is targeted to grow more than 50% sequentially. Only the headline was available, so this summary does not cover the article body.

This continues an earlier story: Beta Bionics expects 2026 revenue of $124M-$126M and targets Mint launch in Q1 2027

Later: Advanced Energy forecasts Q4 revenue of $735M ± $25M and targets over $5B capacity by end of 2028

Timeline

  1. Seeking Alpha

    Source ↗

    Reports that Iradimed anticipates Q4 revenue of $25M-$26.5M as its 3870 pump output targets 50%+ sequential growth.

Comments

No comments yet.

    to like and comment.

    © 2026 ChordNews